| Literature DB >> 26163030 |
Sang-Wook Yi1, Soon-Ae Shin2, Youn-Jung Lee2.
Abstract
OBJECTIVE: Whether low-intensity telephone-counselling interventions can improve cardiometabolic risk factors in screen-detected people with metabolic syndrome (MetS) is unclear. The aim of this study was to evaluate the effectiveness of a low-intensity, telephone-counselling programme on MetS implemented by the National Health Insurance Service (NHIS) of Korea using regression discontinuity design.Entities:
Keywords: PUBLIC HEALTH
Mesh:
Substances:
Year: 2015 PMID: 26163030 PMCID: PMC4499681 DOI: 10.1136/bmjopen-2015-007603
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Flow of Metabolic Syndrome Management Programme at the National Health Insurance Service (NHIS) in Korea.
Figure 2Flow of the study population.
Sociodemographic and behavioural characteristics by group
| Characteristics | Classification | Total enrollees* | Eligible group* | Intervention group* | Control group* | p Value† | p Value‡ | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| (n=1 147 695) | (n=291 825) | (n=23 968) | (n=855 870) | ||||||||
| n | (%) | n | (%) | n | (%) | n | (%) | ||||
| Age at baseline examination (years) | Mean (SD) | 42.7 | (10.3) | 48.7 | (10.9) | 41.0 | (11.0) | <0.001§ | <0.001¶ | ||
| Gender | Female | 270 964 | (23.6) | 42 547 | (14.6) | 5641 | (23.5) | 228 417 | (26.7) | <0.001 | <0.001 |
| Male | 876 731 | (76.4) | 249 278 | (85.4) | 18 327 | (76.5) | 627 453 | (73.3) | |||
| Beneficiary status | Self-employed | 16 274 | (1.4) | 4822 | (1.7) | 1006 | (4.2) | 11 452 | (1.3) | <0.001 | <0.001 |
| Dependant of a self-employed | 7963 | (0.7) | 1968 | (0.7) | 452 | (1.9) | 5995 | (0.7) | |||
| Employee | 1 098 562 | (95.7) | 278 418 | (95.5) | 20 990 | (87.6) | 820 144 | (95.9) | |||
| Dependant of an employee | 24 101 | (2.1) | 6410 | (2.2) | 1515 | (6.3) | 17 691 | (2.1) | |||
| Premium vigintile** | 5th or below | 258 342 | (22.5) | 62 702 | (21.5) | 7220 | (30.1) | 195 640 | (22.9) | <0.001 | <0.001 |
| 6th-10th | 211 831 | (18.5) | 46 917 | (16.1) | 4557 | (19.0) | 164 914 | (19.3) | |||
| 11th-15th | 337 455 | (29.4) | 86 828 | (29.8) | 6163 | (25.7) | 250 627 | (29.3) | |||
| 16th or above | 340 067 | (29.6) | 95 378 | (32.7) | 6028 | (25.2) | 244 689 | (28.6) | |||
| Smoking†† | Yes | 414 357 | (36.1) | 123 449 | (42.3) | 8380 | (35.0) | 290 908 | (34.0) | <0.001 | <0.001 |
| Drinking†† | Yes | 453 142 | (39.5) | 130 367 | (44.7) | 9492 | (39.6) | 322 775 | (37.7) | <0.001 | <0.001 |
| Physical Inactivity†† | Yes | 392 419 | (34.2) | 104 026 | (35.6) | 8421 | (35.1) | 288 393 | (33.7) | <0.001 | <0.001 |
*Total enrollees consisted of the control and eligible groups. The intervention group was a subset of the eligible group which participated in the counselling programme several months after baseline examinations.
†χ2 Test between the eligible and control groups.
‡χ2 Test between the intervention and control groups.
§One-way analysis of variance between the eligible and control groups.
¶One-way analysis of variance between the intervention and control groups.
**Premium vigintile of a dependant of a self-employed (or an employee) was based on that of their insured (a self-employed or an employee). Premium vigintile was calculated based on data from all citizens insured by the National Health Insurance Service in Korea, but not from the study participants.
††These variables are not smoking, drinking, and physical inactivity status per se answered by each enrollee, rather than an assessment by the attending physicians on the need for improvement of each variable for an enrollee. The attending physicians at health examination made an assessment whether there is a need for improvement in smoking, drinking, and physical inactivity status in each enrollee, based on examinees' answers to the questionnaire and personal interview.
Changes in the value of each component of the metabolic syndrome, the number of metabolic syndrome components, body weight and BMI from baseline by group
| Outcome variables | Classification | Eligible group | Intervention group* | Control group | |||
|---|---|---|---|---|---|---|---|
| (n=291 825) | (n=23 968) | (n=855 870) | |||||
| Mean | (SD) | Mean | (SD) | Mean | (SD) | ||
| Age (years) | Baseline | 42.7 | (10.3) | 48.7 | (10.9) | 41.0 | (11.0) |
| Interval between baseline and follow-up examinations (days) | Baseline | 333.7 | (65.5) | 335.9 | (64.6) | 334.2 | (64.9) |
| The number of MetS components | Baseline | 3.36 | (0.56) | 3.55 | (0.64) | 1.41 | (0.50) |
| by NHIS criteria† | Follow-up | 2.68 | (1.14) | 2.83 | (1.13) | 1.40 | (1.06) |
| Change | −0.68 | (1.12) | −0.72 | (1.10) | −0.01 | (1.02) | |
| p value‡ | <0.001 | <0.001 | <0.001 | ||||
| The number of MetS components | Baseline | 2.96 | (0.74) | 3.20 | (0.77) | 1.20 | (0.58) |
| by modified NCEP criteria§ | Follow-up | 2.33 | (1.18) | 2.53 | (1.17) | 1.20 | (1.01) |
| Change | −0.63 | (1.17) | −0.68 | (1.16) | −0.003 | (1.04) | |
| p value‡ | <0.001 | <0.001 | 0.003 | ||||
| Systolic blood pressure (mm Hg) | Baseline | 131.2 | (12.7) | 135.7 | (14.9) | 122.3 | (12.6) |
| Follow-up | 128.0 | (13.4) | 130.2 | (14.8) | 121.7 | (12.7) | |
| Change | −3.1 | (13.9) | −5.5 | (15.6) | −0.7 | (13.1) | |
| p value‡ | <0.001 | <0.001 | <0.001 | ||||
| Diastolic blood pressure (mm Hg) | Baseline | 82.6 | (9.4) | 84.9 | (10.7) | 76.8 | (8.9) |
| Follow-up | 80.9 | (9.7) | 81.9 | (10.4) | 76.6 | (9.0) | |
| Change | −1.7 | (10.4) | −3.0 | (11.3) | −0.2 | (9.6) | |
| p value‡ | <0.001 | <0.001 | <0.001 | ||||
| Triglyceride (mg/dL) | Baseline | 230.9 | (152.6) | 252.7 | (179.2) | 125.3 | (82.0) |
| Follow-up | 206.4 | (154.2) | 211.7 | (161.0) | 128.6 | (93.8) | |
| Change | −24.5 | (159.6) | −41.0 | (170.3) | 3.3 | (91.6) | |
| p value‡ | <0.001 | <0.001 | <0.001 | ||||
| Fasting plasma glucose (mg/dL) | Baseline | 105.7 | (26.3) | 115.2 | (37.2) | 94.0 | (15.3) |
| Follow-up | 103.9 | (26.7) | 110.7 | (34.0) | 94.6 | (15.6) | |
| Change | −1.8 | (23.6) | −4.5 | (30.8) | 0.6 | (15.8) | |
| p value‡ | <0.001 | <0.001 | <0.001 | ||||
| Waist circumference (cm) | Baseline | 87.8 | (7.5) | 87.9 | (7.7) | 80.6 | (8.0) |
| Follow-up | 87.7 | (7.8) | 87.5 | (7.9) | 80.9 | (8.2) | |
| Change | −0.1 | (5.2) | −0.4 | (5.3) | 0.3 | (5.1) | |
| p value‡ | <0.001 | <0.001 | <0.001 | ||||
| HDL cholesterol (mg/dL) | Baseline | 47.1 | (19.1) | 47.2 | (17.6) | 55.4 | (20.0) |
| Follow-up | 47.9 | (14.9) | 48.4 | (15.3) | 55.2 | (17.1) | |
| Change | 0.8 | (20.3) | 1.2 | (19.2) | −0.1 | (21.1) | |
| p value‡ | <0.001 | <0.001 | <0.001 | ||||
| Weight (kg) | Baseline | 77.1 | (11.6) | 74.6 | (12.0) | 67.7 | (11.3) |
| Follow-up | 77.0 | (11.9) | 74.2 | (12.1) | 68.1 | (11.6) | |
| Change | −0.1 | (3.3) | −0.4 | (3.2) | 0.4 | (3.0) | |
| p value‡ | <0.001 | <0.001 | <0.001 | ||||
| Body mass index (kg/m2) | Baseline | 26.7 | (2.9) | 26.7 | (3.0) | 23.9 | (2.9) |
| Follow-up | 26.7 | (3.1) | 26.5 | (3.1) | 24.0 | (3.0) | |
| Change | −0.05 | (1.1) | −0.2 | (1.1) | 0.1 | (1.1) | |
| p value‡ | <0.001 | <0.001 | <0.001 | ||||
p Values, which were calculated by one-way analysis of variance between the eligible and control groups, and between the intervention and control groups, were all <0.001 for all outcome variables.
*The intervention group was a subset of the eligible group which participated in the counselling programme.
†NHIS criteria applied the NCEP criteria1 with the Korean waist circumference cut-off and BMI. (Abdominal obesity as a waist circumference of ≥90 cm in men and ≥85 cm in women or a BMI ≥25 kg/m2).
‡Paired t test of within-group change from baseline.
§NCEP criteria1 with the Korean waist circumference cut-off (abdominal obesity as a waist circumference of ≥90 cm in men and ≥85 cm in women).
BMI, body mass index; HDL, high-density lipoprotein; MetS, metabolic syndrome; NCEP, National Cholesterol Education Programme of the USA; NHIS, the National Health Insurance Service of Korea.
Intervention effects on the metabolic syndrome-related risk factors by multiple regression analysis (ANCOVA models*)
| Outcome variables | Eligible group vs control group | Intervention group vs control group† | ||||
|---|---|---|---|---|---|---|
| Intervention effect‡ | 95% CI | p Value | Intervention effect‡ | 95% CI | p Value | |
| All participants | ||||||
| The number of MetS components by NHIS criteria§ | 0.03 | (0.02 to 0.03) | <0.001 | −0.02 | (−0.04 to −0.01) | 0.001 |
| The number of MetS components by modified NCEP criteria¶ | 0.01 | (0.00 to 0.02) | 0.006 | −0.05 | (−0.06 to −0.03) | <0.001 |
| Systolic BP (mm Hg) | −0.16 | (−0.25 to −0.07) | 0.001 | −0.85 | (−1.02 to −0.68) | <0.001 |
| Diastolic BP (mm Hg) | −0.06 | (−0.12 to 0.01) | 0.086 | −0.63 | (−0.75 to −0.50 | <0.001 |
| Triglyceride (mg/dL) | 2.52 | (1.72 to 3.32) | <0.001 | −1.57 | (−2.89 to −0.25) | 0.020 |
| Fasting plasma glucose (mg/dL) | 0.29 | (0.16 to 0.42) | <0.001 | 2.03 | (1.81 to 2.25) | <0.001 |
| Waist circumference (cm) | 0.0004 | (−0.04 to 0.04) | 0.983 | −0.09 | (−0.16 to −0.02) | 0.017 |
| HDL cholesterol (mg/dL) | 0.12 | (0.00 to 0.25) | 0.052 | 0.17 | (−0.07 to 0.42) | 0.172 |
| Weight (kg) | −0.02 | (−0.04 to 0.01) | 0.143 | −0.19 | (−0.24 to −0.15) | <0.001 |
| Body mass index (kg/m2) | −0.004 | (−0.01 to 0.00) | 0.395 | −0.07 | (−0.09 to −0.05) | <0.001 |
| Participants with a relevant MetS component** | ||||||
| Systolic BP (mm Hg) | −0.06 | (−0.18 to 0.07) | 0.377 | −1.29 | (−1.53 to−1.05) | <0.001 |
| Diastolic BP (mm Hg) | 0.04 | (−0.05 to 0.13) | 0.399 | −0.81 | (−0.98 to−0.63) | <0.001 |
| Triglyceride (mg/dL) | −1.87 | (−3.37 to −0.36) | 0.015 | −7.58 | (−10.3 to −4.89) | <0.001 |
| Fasting plasma glucose (mg/dL) | −0.05 | (−0.32 to 0.21) | 0.691 | 0.52 | (0.08 to 0.96) | 0.020 |
| Waist circumference (cm) | 0.08 | (0.03 to 0.13) | 0.002 | 0.05 | (−0.05 to 0.15) | 0.328 |
| HDL cholesterol (mg/dL) | −0.12 | (−0.31 to 0.08) | 0.243 | 0.90 | (0.51 to 1.29) | <0.001 |
| Weight (kg) | 0.01 | (−0.03 to 0.05) | 0.618 | −0.08 | (−0.15 to 0.00) | 0.044 |
| Body mass index (kg/m2) | 0.01 | (−0.01 to 0.02) | 0.356 | −0.03 | (−0.05 to 0.00) | 0.044 |
*Baseline measurements (the number of MetS components by NHIS criteria, systolic BP, diastolic BP, triglyceride, fasting glucose, HDL cholesterol, waist circumference, weight, body mass index), age at baseline, gender, health insurance beneficiary status, health insurance premium vigintile, smoking, drinking, physical inactivity and interval between baseline and follow-up examinations (days) were included in the model as covariates.
†The intervention group was a subset of the eligible group which participated in the counselling programme.
‡Negative values mean that the outcome variable is decreased more from the baseline in the intervention group (or eligible group) than in the control group.
§NHIS criteria applied the NCEP criteria1 with the Korean waist circumference cut-off and BMI (abdominal obesity as a waist circumference of ≥90 cm in men and ≥85 cm in women or a BMI ≥25 kg/m2 in both sexes).
¶NCEP criteria1 with the Korean waist circumference cut-off (abdominal obesity as a waist circumference of ≥90 cm in men and ≥85 cm in women).
**For example, analysis of systolic BP was restricted to those having elevated BP components at baseline, namely those having systolic BP ≥130 or diastolic BP ≥85 mm Hg.
ANCOVA, analysis of covariance; BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; MetS, metabolic syndrome; NCEP, National Cholesterol Education Programme of USA; NHIS, the National Health Insurance Service of Korea.